DOI:

10.1016/j.thromres.2020.05.001

Pharmacol Res. 2020 Apr 26:104827. doi: 10.1016/j.phrs.2020.104827. [Epub ahead of print]
Tetrahydrobiopterin in energy metabolism and metabolic diseases.
Kim HK1, Han J2.
Author information
Abstract

Tetrahydrobiopterin (BH4) is an endogenous cofactor for various enzymatic conversions of essential biomolecules including nitric oxide, tyrosine, dopamine, serotonin and phenylalanine. Depending on the physiological functions of these molecules, BH4 plays multiple roles in the cardiovascular, immune, nervous and endocrine systems. A deficiency of BH4 or an imbalance of the redox state of biopterin has been implicated in various cardiovascular and metabolic diseases. Therefore, supplementation with BH4 is considered as a therapeutic option for these diseases. In addition to the classical nitric oxide synthase (NOS)-dependent role of BH4, recent studies proposed novel NOS-independent roles of BH4 in health and disease conditions. This article reviews the updated role of BH4 in mitochondrial regulation, energy metabolism and cardiovascular and metabolic diseases.

Copyright © 2020. Published by Elsevier Ltd.
KEYWORDS:

Tetrahydrobiopterin; cardiovascular diseases; energy metabolism; mitochondria

PMID:
32348841
DOI:
10.1016/j.phrs.2020.104827

Leabright's Blog

Just another WordPress.com weblog

WordPress.com

WordPress.com is the best place for your personal blog or business site.